| Bioactivity | Thalidomide-5-NH2-CH2-COOH (compound 114) is a potent and selective inhibitor of tropomyosin receptor kinase (trk). Thalidomide-5-NH2-CH2-COOH is a ligand of E3 ligase. Thalidomide-5-NH2-CH2-COOH has the potential for researching one or more diseases (extracted from patent WO2021170109A1)[1]. | ||||||||||||
| Target | trk | ||||||||||||
| Name | Thalidomide-5-NH2-CH2-COOH | ||||||||||||
| CAS | 2412056-27-8 | ||||||||||||
| Formula | C15H13N3O6 | ||||||||||||
| Molar Mass | 331.28 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Jing Liu, et al. Tropomyosin receptor kinase (trk) degradation compounds and methods of use. Patent WO2021170109A1. |
Thalidomide-5-NH2-CH2-COOH
CAS: 2412056-27-8 F: C15H13N3O6 W: 331.28
Thalidomide-5-NH2-CH2-COOH (compound 114) is a potent and selective inhibitor of tropomyosin receptor kinase (trk).
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.